Press Releases

Gilead Sciences to Present at Two Upcoming Investor Conferences

- 16th Annual BIO CEO & Investor Conference on February 11th -
- 2014 Leerink Swann Healthcare Conference on February 12th -
- Webcast Available Through Gilead Corporate Website -

FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 10, 2014-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company will be webcasting its corporate presentation at two upcoming investor conferences: the 16th Annual BIO CEO & Investor Conference and the 2014 Leerink Swann Healthcare Conference, both taking place in New York.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will provide an overview of the company at the BIO conference on Tuesday, February 11 at 10:00 a.m. Eastern Time (ET) and the Leerink Swann conference on Wednesday, February 12 at 10:40 a.m. ET.

To access the live webcast or a replay via the internet log on to Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations